Description

2-Amino-1-(3-Cyano-5,6,7,8-Tetrahydro-4H-Cyclohepta[B]Thien-2-Yl)-5-Oxo-4-(3-Thienyl)-1,4,5,6,7,8-Hexahydro-3-Quinolinecarbonitrile is a sophisticated heterocyclic organic compound featuring fused quinoline, thiophene, and cycloheptane rings, making it a valuable advanced intermediate for pharmaceutical research and development. Its complex polycyclic structure is designed to interact with specific biological targets, offering significant potential in the discovery of novel therapeutic agents. This high-purity building block is primarily utilized by R&D chemists and process development scientists in the pharmaceutical and biotechnology industries.

Application

• Pharmaceutical Intermediate: Serves as a critical precursor in the synthesis of novel drug candidates, particularly for central nervous system (CNS) and oncology targets.
• Medicinal Chemistry Research: Used as a scaffold for structure-activity relationship (SAR) studies and high-throughput screening libraries.
• Chemical Biology Probe: Acts as a tool compound for investigating enzyme function and protein-ligand interactions in biological systems.
• Process Chemistry Development: Employed in the scale-up and optimization of synthetic routes for active pharmaceutical ingredients (APIs).
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations specializing in custom synthesis and development services for the life sciences sector.

Basic Information

Product Name	2-Amino-1-(3-Cyano-5,6,7,8-Tetrahydro-4H-Cyclohepta[B]Thien-2-Yl)-5-Oxo-4-(3-Thienyl)-1,4,5,6,7,8-Hexahydro-3-Quinolinecarbonitrile
CAS No.	312266-39-0
Molecular Formula	C24H20N4OS2
Molecular Weight	444.57 g/mol
Synonyms	2-Amino-1-(3-cyano-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophen-2-yl)-5-oxo-4-(thiophen-3-yl)-1,4,5,6,7,8-hexahydroquinoline-3-carbonitrile; 2-Amino-1-(3-cyano-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)-5-oxo-4-(3-thienyl)-4,5,6,7-tetrahydro-1H-quinoline-3-carbonitrile (related isomer); CAS 312266-39-0; Hexahydro-3-quinolinecarbonitrile derivative; Fused thienyl-quinoline intermediate; Advanced pharmaceutical building block
EINECS	Contact for details

Quality Control

Our production of this advanced intermediate adheres to strict quality management protocols to ensure batch-to-batch consistency and high purity suitable for research and development. Each lot is characterized using advanced analytical techniques including HPLC, NMR, and mass spectrometry. A comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles is provided with every shipment to support your regulatory and development documentation.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This compound is hygroscopic (moisture-sensitive) and should be handled under dry conditions to maintain stability.

Specification

Item	Specification
Appearance	Off-white to light yellow crystalline powder
Identification (HPLC)	Conforms to reference standard
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.5%
Single Unknown Impurity (HPLC)	≤ 1.0%
Total Impurities (HPLC)	≤ 3.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.